Commentary
Podcast
Pharmacists from Mayo Clinic recap some of the latest treatment opportunities to advance patient care in the oncology space.
This episode recaps some of the latest treatment opportunities to advance patient care in the oncology space, shared by oncology pharmacists from Mayo Clinic. We start by speaking with Jodi Taraba, PharmD, MS, BCOP, a breast cancer clinical pharmacist at Mayo Clinic. She offers insights into the pivotal role of pharmacists in driving clinical trial research. Next, we spoke with Candy Pesky, PharmD, BCPS, BCOP, a cancer center care team pharmacist with Mayo Clinic in Rochester, Minnesota. She shares insights into how pharmacists can facilitate patient access to enrollment in clinical trials, Lastly, we spoke with Scott Soefje, PharmD, BCOP, FCCP, FHOPA, MBA, director of pharmacy cancer care at Mayo Clinic. He discusses the pivotal role of oncology pharmacists.
FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia